Baseline corticosteroid use and outcomes in non–small cell lung cancer patients receiving immune checkpoint inhibitors, stratified by indication.
Angelina Lim, Kenneth Nguyen, Fumito Ito, Jorge J. Nieva et autres
11184 Background: Baseline systemic corticosteroids are often prescribed to patients with non-small cell lung cancer (NSCLC) initiating immune checkpoint inhibitors (ICIs). Prior studies associating steroids with reduced ICI efficacy have largely treated steroid exposure as binary without accounting for indication. We evaluated …
us (code pays fourni par la source)
0 citations
Journal of Clinical Oncology